Aims & Scope

The Kollins Journal of Oncology (KJO) is dedicated to publishing high-quality research that advances the understanding of cancer biology and disease mechanisms. The journal welcomes original research articles, review articles, systematic reviews, case reports, short communications, clinical investigations, and emerging perspectives. Through the dissemination of rigorous scientific evidence, KJO aims to support the development of innovative diagnostic and therapeutic strategies and promote excellence in evidence-based Oncology practice.

The journal welcomes submissions in, but not limited to, the following areas:

• Cancer Biology and Tumor Pathogenesis
• Molecular and Cellular Oncology
• Cancer Genetics, Genomics, and Epigenetics
• Biomarkers and Molecular Diagnostics
• Precision Oncology and Personalized Medicine
• Cancer Screening and Early Detection
• Immunotherapy and Immune-Oncology
• Tumor Microenvironment and Cancer Progression
• Metastasis and Tumor Dissemination
• Chemotherapy and Drug Resistance
• Radiation Oncology and Radiotherapy Innovations
• Surgical Oncology
• Clinical Oncology and Cancer Therapeutics
• Translational Oncology Research
• Cancer Epidemiology and Population Studies
• Pediatric Oncology
• Gynecologic Oncology
• Breast Cancer Research
• Lung Cancer and Thoracic Oncology
• Gastrointestinal and Hepatobiliary Oncology
• Hematologic Malignancies
• Neuro-Oncology and Brain Tumors
• Clinical Trials and Therapeutic Development
• Artificial Intelligence and Digital Technologies in Oncology
• Cancer Prevention and Risk Assessment
• Palliative Care and Supportive Oncology

The journal encourages multidisciplinary research that bridges laboratory discoveries, clinical applications, and public health initiatives to improve cancer prevention, diagnosis, treatment, and survivorship.
 

• Dissemination of high-quality research in cancer science and clinical oncology.
• Advancement of knowledge on cancer biology, tumor progression, and disease mechanisms.
• Promotion of innovative diagnostic technologies and therapeutic strategies.
• Support for translational research connecting laboratory discoveries with clinical practice.
• Encouragement of multidisciplinary collaboration among oncology researchers and healthcare professionals.
• Enhancement of precision medicine and personalized cancer care approaches.
• Facilitation of global knowledge exchange in oncology and cancer research.
• Contribution to improved patient outcomes, cancer prevention, and healthcare advancement.

All articles published in the Kollins Journal of Oncology are made available under the Creative Commons Attribution License (CC BY 4.0) (http://creativecommons.org/licenses/by/4.0/). Which permits unrestricted use, distribution and reproduction in any medium, provided the original work & properly cited.
 

Oncology Cancer Research Cancer Biology Tumour Microenvironment Molecular Oncology Cancer Genetics Genomics Transcriptomics Epigenetics Biomarkers Diagnostic Markers Cancer Diagnostics Precision Oncology Personalized Medicine Immunotherapy Immune-Oncology Translational Oncology Metastasis Tumour Progression Chemotherapy Drug Resistance Radiotherapy Radiation Oncology Surgical Oncology Cancer Screening Early Detection Cancer Epidemiology Hematologic Malignancies Paedia